Thermo Fisher Scientific is a global leader in providing scientific instruments, reagents, and consumables, with a focus on advancing healthcare, life sciences, and laboratory workflows
The company supports a diverse range of customers, including researchers, clinical laboratories, and pharmaceutical companies, by offering innovative solutions that enable breakthroughs in areas such as diagnostics, drug development, and environmental analysis. With a commitment to quality and efficiency, Thermo Fisher Scientific plays a crucial role in enhancing productivity and scientific discovery across various disciplines while promoting better health outcomes worldwide.
Life sciences company Thermo Fisher (NYSETMO) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 4.7% year on year to $11.4 billion. Its non-GAAP profit of $6.10 per share was 2.7% above analysts’ consensus estimates.
Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top S&P500 gainers and losers in today's session.
Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Thursday. Stay informed about the latest market trends.
Katy Huberty, the Global Head of Research at Morgan Stanley, has spotlighted 20 stocks from companies that are likely to see significant benefits from the adoption of Artificial Intelligence (AI).
Companies with strong cash flow and a history of impressing Wall Street analysts may make excellent prospects for 2025; TMO, ET, and NTES are three to watch.
With the downfall of Covid-19, pharmaceutical companies turned to oncology in search for their next growth story. Earlier in October, Pfizer Inc (NYSEPFE) reported its third quarter revenue grew 14% on an operational basis due to approved cancer products from Seagen it acquired last December.
